Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

Whereas neuroblastoma (NB) with MYCN amplification presents a poor prognosis, no single marker allows to reliably predict outcome in tumours without MYCN amplification. We report here an extensive analysis of 147 NB samples at diagnosis, without MYCN amplification, by chromosomal comparative genomic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schleiermacher, G, Michon, J, Huon, I, d'Enghien, C Dubois, Klijanienko, J, Brisse, H, Ribeiro, A, Mosseri, V, Rubie, H, Munzer, C, Thomas, C, Valteau-Couanet, D, Auvrignon, A, Plantaz, D, Delattre, O, Couturier, J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Genetics and Genomics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360301/
https://ncbi.nlm.nih.gov/pubmed/17579628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603820
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados